triazoles has been researched along with Disorders of Excessive Somnolence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Earl, DC; Van Tyle, KM | 1 |
| Hashioka, S; Inagaki, M; Izuhara, M; Kawano, K; Otsuki, K | 1 |
| Alsaad, AM; Koren, G | 1 |
| Brittain, C; Foster, J; Jackson, K; McColm, J; Soon, D; Suriyapperuma, S; Swanson, S; Tauscher-Wisniewski, S | 1 |
| Benca, RM; Connor, KM; Herring, WJ; Hutzelmann, J; Krystal, AD; Lines, C; Matzura-Wolfe, D; Michelson, D; Roth, T; Snavely, DB; Snyder, E; Walsh, JK; Zhang, Y | 1 |
| Doyle, T; Levy, R; Marriott, D; Ray, J | 1 |
| Conry, J; Krauss, G; LoPresti, A; Mann, A; Narurkar, M; Wheless, JW | 1 |
3 review(s) available for triazoles and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
New pharmacologic agents for insomnia and hypersomnia.
Topics: Azepines; Carbamates; Dementia; Disorders of Excessive Somnolence; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Phenylalanine; Piperidines; Pyridines; Pyrimidines; Sleep Aids, Pharmaceutical; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Trazodone; Triazoles; Zolpidem | 2020 |
Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials.
Topics: Anticonvulsants; Central Nervous System Diseases; Disorders of Excessive Somnolence; Dizziness; Drug Resistance; Epilepsy; Fatigue; Headache; Humans; Randomized Controlled Trials as Topic; Risk; Triazoles | 2014 |
Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies.
Topics: Adolescent; Age Factors; Anticonvulsants; Child; Child, Preschool; Clinical Trials as Topic; Disorders of Excessive Somnolence; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Headache; Humans; Male; Treatment Outcome; Triazoles; Vomiting | 2009 |
2 trial(s) available for triazoles and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Evaluation of single and multiple doses of a novel mGlu2 agonist, a potential antipsychotic therapy, in healthy subjects.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Bridged Bicyclo Compounds; Cohort Studies; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Half-Life; Headache; Healthy Volunteers; Humans; Male; Middle Aged; Nausea; Placebos; Prodrugs; Receptors, Metabotropic Glutamate; Triazoles; Vomiting; Young Adult | 2017 |
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.
Topics: Adult; Aged; Azepines; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Male; Middle Aged; Polysomnography; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Statistics as Topic; Time Factors; Treatment Outcome; Triazoles | 2017 |
2 other study(ies) available for triazoles and Disorders of Excessive Somnolence
| Article | Year |
|---|---|
Prompt improvement of difficulty with sleep initiation and waking up in the morning and daytime somnolence by combination therapy of suvorexant and ramelteon in delayed sleep-wake phase disorder: a case series of three patients.
Topics: Adult; Azepines; Disorders of Excessive Somnolence; Female; Humans; Indenes; Male; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles; Young Adult | 2021 |
Posaconazole-induced topiramate toxicity.
Topics: Anorexia; Anticonvulsants; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Disorders of Excessive Somnolence; Drug Interactions; Fructose; Humans; Male; Middle Aged; Stupor; Topiramate; Triazoles | 2009 |